Management of Oral Mucositis Induced by Cancer Therapy: A Review of Pharmacological Prevention and Treatment
DOI:
https://doi.org/10.68041/johdt.v1i1/05Keywords:
Drug Therapy, Mucositis, Neoplasms, Oral Ulcer, Prevention and Control, Radiotherapy, StomatitisAbstract
Oral mucositis (OM) is a common side effect of cancer treatment that results in painful mucosal ulceration, decreased oral intake, and diminished quality of life. Although supportive care has made improvements, there is still a problem with its prevention and treatment. This mini-review examines the pharmacological prevention and management of cancer therapy-induced OM with emphasis on clinical evidence and limitations. Benzydamine, palifermin (in certain high-risk groups), and nutritional agents of varying levels of evidence are used in preventive interventions. Treatment of mucositis once it has occurred is based on topical and systemic analgesics and treatment of secondary infections and complications. There is some inconsistent evidence for mucosal-protective and tissue-repair agents, and it is important to differentiate between symptom relief and improvement of mucosal function. The choice of intervention should depend on the patient's cancer treatment plan, the severity of the mucositis, and the patient's characteristics. More carefully designed clinical trials with consistent endpoints are required to determine comparative effectiveness and to maximize tailored management.
References
1. Lalla RV, Bowen J, Barasch A, Elting L, Epstein J, Keefe DM, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014;120(10):1453-61. https://doi.org/10.1002/cncr.28592 DOI: https://doi.org/10.1002/cncr.28592
2. Sonis, S. The pathobiology of mucositis. Nat Rev Cancer. 2004;4(4):277-84. https://doi.org/10.1038/nrc1318 DOI: https://doi.org/10.1038/nrc1318
3. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer‐Jensen M, et al. Perspectives on cancer therapy‐induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004;100(S9):1995-2025. https://doi.org/10.1002/cncr.20162 DOI: https://doi.org/10.1002/cncr.20162
4. Berger K, Schopohl D, Bollig A, Strobach D, Rieger C, Rublee D, et al. Burden of oral mucositis: a systematic review and implications for future research. Oncol Res Treat. 2018;41(6):399-405. https://doi.org/10.1159/000487085 DOI: https://doi.org/10.1159/000487085
5. Hong CH, Gueiros LA, Fulton JS, Cheng KK, Kandwal A, Galiti D, et al. Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2019;27(10):3949-67. https://doi.org/10.1007/s00520-019-04848-4 DOI: https://doi.org/10.1007/s00520-019-04848-4
6. Al-Rudayni AH, Gopinath D, Maharajan MK, Menon RK. Impact of oral mucositis on quality of life in patients undergoing oncological treatment: a systematic review. Transl Cancer Res. 2020;9(4):3126. https://doi.org/10.21037/tcr.2020.02.77 DOI: https://doi.org/10.21037/tcr.2020.02.77
7. Shetty SS, Maruthi M, Dhara V, de Arruda JA, Abreu LG, Mesquita RA, et al. Oral mucositis: Current knowledge and future directions. Dis Mon. 2022 ;68(5):101300. https://doi.org/10.1016/j.disamonth.2021.101300 DOI: https://doi.org/10.1016/j.disamonth.2021.101300
8. Bowen J, Al-Dasooqi N, Bossi P, Wardill H, Van Sebille Y, Al-Azri A, et al. The pathogenesis of mucositis: updated perspectives and emerging targets. Support Care Cancer. 2019;27(10):4023-33. https://doi.org/10.1007/s00520-019-04893-z DOI: https://doi.org/10.1007/s00520-019-04893-z
9. Peterson DE, Bensadoun RJ, Roila F, ESMO Guidelines Working Group. Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann Oncol. 2011;22:vi78-84. https://doi.org/10.1093/annonc/mdr391 DOI: https://doi.org/10.1093/annonc/mdr391
10. Palmer MK. WHO handbook for reporting results of cancer treatment. British journal of cancer. 1982;45(3):484. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC2010938/ DOI: https://doi.org/10.1038/bjc.1982.83
11. Wardill HR, Sonis ST, Blijlevens NM, Van Sebille YZ, Ciorba MA, Loeffen EA, et al. Prediction of mucositis risk secondary to cancer therapy: a systematic review of current evidence and call to action. Support Care Cancer. 2020;28(11):5059-73. https://doi.org/10.1007/s00520-020-05579-7 DOI: https://doi.org/10.1007/s00520-020-05579-7
12. Al-Dasooqi N, Sonis ST, Bowen JM, Bateman E, Blijlevens N, Gibson RJ, et al. Emerging evidence on the pathobiology of mucositis. Support Care Cancer. 2013;21(7):2075-83. https://doi.org/10.1007/s00520-013-1810-y DOI: https://doi.org/10.1007/s00520-013-1810-y
13. Ariyawardana A, Cheng KK, Kandwal A, Tilly V, Al-Azri AR, Galiti D, et al. Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2019;27(10):3985-95. https://doi.org/10.1007/s00520-019-04888-w DOI: https://doi.org/10.1007/s00520-019-04888-w
14. Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T, et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med. 2004;351(25):2590-8.
https://doi.org/10.1056/NEJMoa040125 DOI: https://doi.org/10.1056/NEJMoa040125
15. Amiri Khosroshahi R, Talebi S, Zeraattalab-Motlagh S, Imani H, Rashidi A, Travica N, et al. Nutritional interventions for the prevention and treatment of cancer therapy-induced oral mucositis: an umbrella review of systematic reviews and meta-analysis. Nutr Rev. 2023;81(9):1200-12. https://doi.org/10.1093/nutrit/nuac105 DOI: https://doi.org/10.1093/nutrit/nuac105
16. Peng TR, Tsai FP, Wu TW. Effects of various treatments for preventing oral mucositis in cancer patients: A network meta-analysis. PLoS One. 2022;17(12):e0278102. https://doi.org/10.1371/journal.pone.0278102 DOI: https://doi.org/10.1371/journal.pone.0278102
17. Liu YC, Wu CR, Huang TW. Preventive effect of probiotics on oral mucositis induced by cancer treatment: a systematic review and meta-analysis. Int J Mol Sci. 2022;23(21):13268. https://doi.org/10.3390/ijms232113268 DOI: https://doi.org/10.3390/ijms232113268
18. Correa ME, Cheng KK, Chiang K, Kandwal A, Loprinzi CL, Mori T, et al. Systematic review of oral cryotherapy for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2020;28(5):2449-56. https://doi.org/10.1007/s00520-019-05217-x DOI: https://doi.org/10.1007/s00520-019-05217-x
19. Zadik Y, Arany PR, Fregnani ER, Bossi P, Antunes HS, Bensadoun RJ, et al. Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2019;27(10):3969-83. https://doi.org/10.1007/s00520-019-04890-2 DOI: https://doi.org/10.1007/s00520-019-04890-2
20. Saunders DP, Rouleau T, Cheng K, Yarom N, Kandwal A, Joy J, et al. Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2020;28(5):2473-84. https://doi.org/10.1007/s00520-019-05181-6 DOI: https://doi.org/10.1007/s00520-019-05181-6
21. Sio TT, Le-Rademacher JG, Leenstra JL, Loprinzi CL, Rine G, Curtis A, et al. Effect of doxepin mouthwash or diphenhydramine-lidocaine-antacid mouthwash vs placebo on radiotherapy-related oral mucositis pain: the alliance A221304 randomized clinical trial. JAMA. 2019;321(15):1481-90. https://doi.org/10.1001/jama.2019.3504 DOI: https://doi.org/10.1001/jama.2019.3504
22. Coda BA, O'Sullivan B, Donaldson G, Bohl S, Chapman CR, Shen DD. Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation. Pain. 1997;72(3):333-46. https://doi.org/10.1016/S0304-3959(97)00059-6 DOI: https://doi.org/10.1016/S0304-3959(97)00059-6
23. Sarvizadeh M, Hemati S, Meidani M, Ashouri M, Roayaei M, Shahsanai A. Morphine mouthwash for the management of oral mucositis in patients with head and neck cancer. Adv Biomed Res. 2015;4:44. https://doi.org/10.4103/2277-9175.151254 DOI: https://doi.org/10.4103/2277-9175.151254
24. Ana GS, Normando AG, de Toledo IP, Dos Reis PE, Guerra EN. Topical treatment of oral mucositis in cancer patients: a systematic review of randomized clinical trials. Asian Pac J Cancer Prev. 2020;21(7):1851. https://doi.org/10.31557/APJCP.2020.21.7.1851 DOI: https://doi.org/10.31557/APJCP.2020.21.7.1851
25. Gobbo M, Joy J, Guedes H, Shazib MA, Anderson C, Abdalla-Aslan R, et al. Emerging pharmacotherapy trends in preventing and managing oral mucositis induced by chemoradiotherapy and targeted agents. Expert Opin Pharmacother. 2024;25(6):727-742. https://doi.org/10.1080/14656566.2024.2354451 DOI: https://doi.org/10.1080/14656566.2024.2354451
26. Ono K, Ueno T, Kido MA, Hitomi S, Naniwa M, Nakatomi C, et al. Recent advances in the treatment of oral ulcerative mucositis from clinical and basic perspectives. J Oral Biosci. 2024;66(3):504-10. https://doi.org/10.1016/j.job.2024.06.002 DOI: https://doi.org/10.1016/j.job.2024.06.002
27. Braguês R, Marvão MF, Correia P, Silva RM. Oral mucositis management in children under cancer treatment: a systematic review. Cancers. 2024;16(8):1548. https://doi.org/10.3390/cancers16081548 DOI: https://doi.org/10.3390/cancers16081548
28. Coppini M, Caponio VC, Mauceri R, Bizzoca ME, Laino L, Lorenzo‐Pouso AI, et al. Efficacy of topical agents in oral mucositis prevention: Systematic review and network meta‐analysis. Oral Dis. 2024;30(7):4126-44. https://doi.org/10.1111/odi.15046 DOI: https://doi.org/10.1111/odi.15046
29. Lee CC, Chen YW, Kang YN, Chen JH, Chen C, Lu CY, et al. Efficacy of natural products in preventing oral mucositis resulting from cancer therapies: A network meta-analysis of randomized controlled trials. Crit Rev Oncol Hematol. 2024;199:104373. https://doi.org/10.1016/j.critrevonc.2024.104373 DOI: https://doi.org/10.1016/j.critrevonc.2024.104373
30. Joseph B, Mauramo M, Vijayakumary BK, Waltimo T, Anil S, Sorsa T. Photodynamic therapy for oral mucositis in cancer patients-a systematic review and meta-analysis. Photodiagn Photodyn Ther. 2024;50:104424. https://doi.org/10.1016/j.pdpdt.2024.104424 DOI: https://doi.org/10.1016/j.pdpdt.2024.104424
Published
Issue
Section
License
Copyright (c) 2026 Maryum Sana (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Journal of Oral Health and Dental Therapeutics (JOHDT) follows the Attribution Creative Commons-Non commercial (CC BY-NC 4.0) license which allows the users to copy and redistribute the material in any medium or format, remix, transform and build upon the material. The users must give credit to the source and indicate, provide a link to the license, and indicate if changes were made. However, the CC BY-NC 4.0 license restricts the use of material for commercial purposes (Further details are available at website. The Editorial Board of the JOHDT endeavors to ensure the accuracy, integrity, and quality of all published content. However, the responsibility of opinions, interpretations, and conclusions expressed in the published articles rests entirely with the authors and do not necessarily reflect the views of the Editorial Board, publisher, or affiliated institutions.
